“…Moreover, since the launch in 2013 of Intensive Care Medicine Experimental (ICMx), all preclinical research is transferred there. ICM may publish translational research if the reported data relate to clinical outcomes and provide a plausible biological basis for future clinical trials [1,2]. After this initial evaluation, about 60 % of papers are assigned to section editors who further appraise the manuscripts for originality, study design, degree of novelty, quality of reporting (writing, tables and figures), and statistical soundness, as well as competition with other manuscripts being considered for publication in the journal.…”